© 2023 Vial. All rights reserved
- Sub-I (The Sub-Investigator)
- Subcutaneous Fat
- Subjective Endpoints
- Swimmer’s Itch (Cercarial Dermatitis)
- Synthetic Control Arm
- T-cell Transfer Therapy
- TIL Therapy
- Ulcerative Colitis
Stopping rules define a safety criteria primarily used in early phase clinical trials to determine when the study needs to be paused or halted.
These rules are constructed to be in the form of a standardized algorithm based approach that fulfills the regulatory requirements while taking into account the design and anticipated risks of the trial.
Source: Coates, S., Täubel, J., & Lorch, U. (2018). Practical risk management in early phase clinical trials. European Journal of Clinical Pharmacology, 75(4), 483–496. https://doi.org/10.1007/s00228-018-02607-8